Add-on Acquisition • Chemicals

Solvias Acquires Chemic

On June 17, 2021, Solvias acquired chemicals company Chemic

Acquisition Context

This is Solvias’ 1st transaction in the Chemicals sector.
This is Solvias’ 1st transaction in the United States.
This is Solvias’ 1st transaction in Massachusetts.

Explore All 1513 Add-on Acquisition Chemicals Deals - Search the Database Free

M&A Deal Summary
Date	June 17, 2021
Target	Chemic
Sector	Chemicals
Buyer(s)	Solvias
Deal Type	Add-on Acquisition

Target Company

Chemic

Canton, Massachusetts, United States

Chemic is a global contract analytical and outsourcing partner to the pharmaceutical, medical device, and biotech industries. Chemic provides a wide array of analytical and manufacturing resources. Chemic was founded in 1998 and is based in Canton, Massachusetts.

Explore More Deals

Browse All 215,130 Deals

FILTER BY

Buyer Type (PE or Strategic)
Deal Size ($10M to $10B+)
Sector (60 Sectors)
Deal Type
Geography
& More

Search Free

Buyer Overview 1

Buyer

Solvias

Kaiseraugst, Switzerland

Category	Company
Founded	1999
Sector	Life Science

DESCRIPTION

Solvias is contract research, development, and manufacturing. The industries the company serves include pharmaceuticals, biotech, medical device, and cosmetics. Solvias was founded in 1999 and is based in Kaiseraugst, Switzerland.

Deal Context for Buyer	#
Overall	1 of 2
Sector: Chemicals	1 of 1
Type: Add-on Acquisition	1 of 2
State: Massachusetts	1 of 1
Country: United States	1 of 1
Year: 2021	1 of 1

FOLLOWING DEAL

DATE	TARGET	DEAL TYPE	VALUE
2022-07-12	Cergentis Utrecht, Netherlands Cergentis is a genomics-focused biotechnology company providing services and in-house solutions based on its proprietary genomic analysis platform to all leading biopharmaceutical companies and renowned research institutes. Cergentis was founded in 2012 and is based in Utrecht, Netherlands.	Buy	-

DATE

TARGET

DEAL TYPE

VALUE

2022-07-12

Cergentis

Utrecht, Netherlands

Cergentis is a genomics-focused biotechnology company providing services and in-house solutions based on its proprietary genomic analysis platform to all leading biopharmaceutical companies and renowned research institutes. Cergentis was founded in 2012 and is based in Utrecht, Netherlands.

Buy

Explore Related M&A Activity

Chemicals M&A - Add-on Acquisition M&A Deals - Massachusetts M&A - United States M&A - 2021 M&A